Invertase Peptide

Invertase Peptide is an enzyme-based therapeutic candidate being developed by Dandu Biosciences. Invertase, also known as beta-fructofuranosidase, is an enzyme that catalyzes the hydrolysis of sucrose into its constituent monosaccharides, glucose and fructose. While Dandu Biosciences has not publicly disclosed the specific therapeutic indication for this candidate, it is categorized within their enzyme and recombinant peptide pipeline. The program is currently in the analytical transfer stage, which typically involves the transition of analytical methods between laboratories or into a production environment during preclinical development.

Other names

invertase peptide-Dandu Biosciences-enzyme